{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:10:05Z","timestamp":1751436605121,"version":"3.41.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.7759\/cureus.87145","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:48:36Z","timestamp":1751435316000},"source":"Crossref","is-referenced-by-count":0,"title":["Acceleration of Diagnosis and Treatment Initiation Using the Elecsys\u00ae HCV Duo Assay"],"prefix":"10.7759","author":[{"given":"Tadashi","family":"Namisaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Murai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemi","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13630","article-title":"Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer\u00a0in patients with hepatitis C virus infection receiving direct-acting antivirals","volume":"51","author":"Chuaypen N","year":"2021","unstructured":"Chuaypen N, Chittmittrapap S, Avihingsanon A, et al.. Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer\u00a0in patients with hepatitis C virus infection receiving direct-acting antivirals. Hepatol Res. 2021, 51:528-37. 10.1111\/hepr.13630","journal-title":"Hepatol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12216949","article-title":"Real-world efficacy and safety of an 8-week glecaprevir\/pibrentasvir regimen in children and adolescents with chronic hepatitis C-results of a multicenter EpiTer-2 study","volume":"12","author":"Pawlowska M","year":"2023","unstructured":"Pawlowska M, Dobrowolska K, Moppert J, et al.. Real-world efficacy and safety of an 8-week glecaprevir\/pibrentasvir regimen in children and adolescents with chronic hepatitis C-results of a multicenter EpiTer-2 study. J Clin Med. 2023, 12:6949. 10.3390\/jcm12216949","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100428","article-title":"Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: a simulation study","volume":"22","author":"Tanaka J","year":"2022","unstructured":"Tanaka J, Kurisu A, Ohara M, et al.. Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: a simulation study. Lancet Reg Health West Pac. 2022, 22:100428. 10.1016\/j.lanwpc.2022.100428","journal-title":"Lancet Reg Health West Pac"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi H","year":"2020","unstructured":"Razavi H, Sanchez Gonzalez Y, Yuen C, Cornberg M. Global timing of hepatitis C virus elimination in high-income countries. Liver Int. 2020, 40:522-9. 10.1111\/liv.14324","journal-title":"Liver Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu509","article-title":"Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010","volume":"59","author":"Spradling PR","year":"2014","unstructured":"Spradling PR, Tong X, Rupp LB, et al.. Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010. Clin Infect Dis. 2014, 59:976-81. 10.1093\/cid\/ciu509","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-023-02003-4","article-title":"Correction: accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study","volume":"22","author":"Antoniou T","year":"2023","unstructured":"Antoniou T, Pritlove C, Shearer D, Tadrous M, Shah H, Gomes T. Correction: accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study. Int J Equity Health. 2023, 22:214. 10.1186\/s12939-023-02003-4","journal-title":"Int J Equity Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-8. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.01.031","article-title":"Half a diagnosis: gap in confirming infection among hepatitis C antibody-positive patients","volume":"126","author":"McGibbon E","year":"2013","unstructured":"McGibbon E, Bornschlegel K, Balter S. Half a diagnosis: gap in confirming infection among hepatitis C antibody-positive patients. Am J Med. 2013, 126:718-22. 10.1016\/j.amjmed.2013.01.031","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination - a path to global elimination of hepatitis C","volume":"67","author":"Lazarus JV","year":"2017","unstructured":"Lazarus JV, Wiktor S, Colombo M, Thursz M. Micro-elimination - a path to global elimination of hepatitis C. J Hepatol. 2017, 67:665-6. 10.1016\/j.jhep.2017.06.033","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10121570","article-title":"From screening to therapy: anti-HCV screening and linkage to care in a network of general practitioners and a private gastroenterology practice","volume":"10","author":"Petroff D","year":"2021","unstructured":"Petroff D, B\u00e4tz O, Jedrysiak K, et al.. From screening to therapy: anti-HCV screening and linkage to care in a network of general practitioners and a private gastroenterology practice. Pathogens. 2021, 10:1570. 10.3390\/pathogens10121570","journal-title":"Pathogens"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad126","article-title":"Reflex hepatitis C virus viral load testing following an initial positive hepatitis C virus antibody test: a global systematic review and meta-analysis","volume":"77","author":"Tao Y","year":"2023","unstructured":"Tao Y, Tang W, Fajardo E, et al.. Reflex hepatitis C virus viral load testing following an initial positive hepatitis C virus antibody test: a global systematic review and meta-analysis. Clin Infect Dis. 2023, 77:1137-56. 10.1093\/cid\/ciad126","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3138\/jammi-2021-0028","article-title":"HCV reflex testing: a single-sample, low-contamination method that improves the diagnostic efficiency of HCV testing among patients in Alberta, Canada","volume":"7","author":"Thompson LA","year":"2022","unstructured":"Thompson LA, Fenton J, Charlton CL. HCV reflex testing: a single-sample, low-contamination method that improves the diagnostic efficiency of HCV testing among patients in Alberta, Canada. J Assoc Med Microbiol Infect Dis Can. 2022, 7:97-107. 10.3138\/jammi-2021-0028","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2024.105743","article-title":"Performance evaluation of the Abbott Alinity Hepatitis C antigen next assay in a US urban emergency department population","volume":"175","author":"Prostko J","year":"2024","unstructured":"Prostko J, Rothman R, Hsieh YH, et al.. Performance evaluation of the Abbott Alinity Hepatitis C antigen next assay in a US urban emergency department population. J Clin Virol. 2024, 175:105743. 10.1016\/j.jcv.2024.105743","journal-title":"J Clin Virol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2021.07.002","article-title":"Utility of hepatitis C virus core antigen testing for diagnosis and treatment monitoring in HCV infection: a study from India","volume":"39","author":"Kumbhar N","year":"2021","unstructured":"Kumbhar N, Ramachandran K, Kumar G, Rao Pasupuleti SS, Sharma MK, Gupta E. Utility of hepatitis C virus core antigen testing for diagnosis and treatment monitoring in HCV infection: a study from India. Indian J Med Microbiol. 2021, 39:462-6. 10.1016\/j.ijmmb.2021.07.002","journal-title":"Indian J Med Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313771","article-title":"Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active infection for treatment","volume":"19","author":"Kanokudom S","year":"2024","unstructured":"Kanokudom S, Poovorawan K, Nilyanimit P, Suntronwong N, Aeemjinda R, Honsawek S, Poovorawan Y. Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active infection for treatment. PLoS One. 2024, 19:e0313771. 10.1371\/journal.pone.0313771","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1474127","article-title":"Evaluation of a new human immunodeficiency virus antigen and antibody test using light-initiated chemiluminescent assay","volume":"15","author":"Li Y","year":"2025","unstructured":"Li Y, Jin F, Li Y, Li Y, Wang Y, Yang X. Evaluation of a new human immunodeficiency virus antigen and antibody test using light-initiated chemiluminescent assay. Front Cell Infect Microbiol. 2025, 15:1474127. 10.3389\/fcimb.2025.1474127","journal-title":"Front Cell Infect Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00832-24","article-title":"Comparison of a dual antibody and antigen HCV immunoassay to standard of care algorithmic testing","volume":"62","author":"Bui TI","year":"2024","unstructured":"Bui TI, Brown AP, Brown M, Lawless S, Roemmich B, Anderson NW, Farnsworth CW. Comparison of a dual antibody and antigen HCV immunoassay to standard of care algorithmic testing. J Clin Microbiol. 2024, 62:e0083224. 10.1128\/jcm.00832-24","journal-title":"J Clin Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v24i4.10","article-title":"Evaluation of an antigen-antibody \"combination\" enzyme linked immunosorbent assay for diagnosis of hepatitis C virus infections","volume":"24","author":"Odari EO","year":"2014","unstructured":"Odari EO, Budambula NL, Nitschko H. Evaluation of an antigen-antibody \"combination\" enzyme linked immunosorbent assay for diagnosis of hepatitis C virus infections. Ethiop J Health Sci. 2014, 24:343-52. 10.4314\/ejhs.v24i4.10","journal-title":"Ethiop J Health Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14192179","article-title":"Performance of Elecsys\u00ae HCV Duo immunoassay for diagnosis and assessment of treatment response in HCV patients with or without HIV infection","volume":"14","author":"Ananchuensook P","year":"2024","unstructured":"Ananchuensook P, Wongpiyabovorn J, Avihingsanon A, Tangkijvanich P. Performance of Elecsys\u00ae HCV Duo immunoassay for diagnosis and assessment of treatment response in HCV patients with or without HIV infection. Diagnostics (Basel). 2024, 14:2179. 10.3390\/diagnostics14192179","journal-title":"Diagnostics (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00321-7","article-title":"Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update","volume":"9","author":"Cooke GS","year":"2024","unstructured":"Cooke GS, Flower B, Cunningham E, et al.. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update. Lancet Gastroenterol Hepatol. 2024, 9:346-65. 10.1016\/S2468-1253(23)00321-7","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382439-acceleration-of-diagnosis-and-treatment-initiation-using-the-elecsys-hcv-duo-assay","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:48:36Z","timestamp":1751435316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382439-acceleration-of-diagnosis-and-treatment-initiation-using-the-elecsys-hcv-duo-assay"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.87145","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}